98720113 - KNOMATIC

Information

• Trademark
• 98720113

• Source

• Serial Number

  98720113

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  August 27, 2024
  a year ago

• Transaction Date

  July 15, 2025
  3 months ago

• Status Date

  July 14, 2025
  3 months ago

• Location Date

  July 14, 2025
  3 months ago

• First Use Anywhere Date

  August 19, 2024
  a year ago

• First Use In Commerce Date

  August 19, 2024
  a year ago

• Status Code

  641

• Current Location

  TMO LAW OFFICE 127

  Employee Name

  THOMA, GABRIELLE

• Attorney Docket Number

  MOT24.00002

  Attorney Name

  Gregory B. Coy

  Law Office Assigned Location Code

  N90

• Owners

  • MOMA Therapeutics, Inc.

Case File Statements

• GS0051: chemical and biochemical preparations and substances for medical purposes for treatment and diagnosis of cancer, autoimmune disease, and other diseases that involve the functionality of highly dynamic proteins; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders
• GS0421: drug discovery services; pharmaceutical research services; pharmaceutical products development; pharmaceutical research and development; pharmaceutical drug development services; consulting services in the field of pharmaceutical research and development; technical consulting in the field of pharmaceutical studies; technical research in the field of pharmaceutical studies; research and development services of new pharmaceutical products; research and development in the pharmaceutical and biotechnology fields; providing medical research information in the field of pharmaceuticals; providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research in the field of bioinformatics; biological and bio-technology analysis services; DNA sequencing technology research; research in the field of DNA mutation; DNA analysis services for scientific research purposes; providing genetic science information; scientific research consulting in the field of pharmaceuticals and drug discovery; medical and scientific research in the field of proteomics; scientific research for medical purposes in the field of proteomics; drug discovery services that utilize structural analysis, hit finding techniques and computational analysis and targets diseases related to highly dynamic proteins; drug design; analysis of structure activity relationships; drug discovery; pharmaceutical research and development; medical research and development; DNA encoded library (DEL) screening; genetic sequencing services; using artificial intelligence (AI) for drug discovery, pharmaceutical research and development, and medical research and development; using machine learning for drug discovery, pharmaceutical research and development, and medical research and development; drug discovery services targeting diseases related to highly dynamic proteins by utilizing structural analysis, hit finding techniques and computational analysis; drug discovery services for use in developing and prioritizing lead compounds for drug development; drug discovery services in the fields of biochemistry, biophysics, structural biology and chemistry; drug discovery services in the nature of a knowledge based drug discovery platform; drug discovery services in the nature of data analysis software for use in drug discovery; drug discovery services in the nature of drug discovery software utilizing hit finding techniques

Case File Event Statements

• 8/27/2024 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 1/17/2025 - 9 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 3/4/2025 - 8 months ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 3/11/2025 - 7 months ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/11/2025 - 7 months ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 3/11/2025 - 7 months ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 6/10/2025 - 4 months ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/10/2025 - 4 months ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 6/10/2025 - 4 months ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/14/2025 - 3 months ago

  10 - NON-FINAL ACTION WRITTEN Type: CNRT

• 7/14/2025 - 3 months ago

  12 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 7/14/2025 - 3 months ago

  11 - NON-FINAL ACTION E-MAILED Type: GNRT